DRD2 encodes dopamine receptor D2 and the binding ofdopaminergic agents such as bromocriptine to dopamine receptors is used to treatT2D symptoms including hyperglycemia, insulin resistance, free fatty acids, andTG [62]. This evidence concerns the gene DRD2 and Hyperglycemia.